Caroline Brennetot
Caroline Brennetot
Inserm U830 Institut Curie
Verified email at curie.fr
Title
Cited by
Cited by
Year
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ...
Oncogene 26 (1), 158-163, 2007
2472007
JUN Oncogene Amplification and Overexpression Block Adipocytic Differentiation in Highly Aggressive Sarcomas
O Mariani, C Brennetot, JM Coindre, N Gruel, C Ganem, O Delattre, ...
Cancer cell 11 (4), 361-374, 2007
1732007
Two types of chromosome 1p losses with opposite significance in gliomas
A Idbaih, Y Marie, G Pierron, C Brennetot, K Hoang‐Xuan, M Kujas, ...
Annals of neurology 58 (3), 483-487, 2005
1732005
BRAF mutations characterize colon but not gastric cancer with mismatch repair deficiency
C Oliveira, M Pinto, A Duval, C Brennetot, E Domingo, E Espín, ...
Oncogene 22 (57), 9192-9196, 2003
1572003
MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone
F Dujardin, MBN Binh, C Bouvier, A Gomez-Brouchet, F Larousserie, ...
Modern Pathology 24 (5), 624-637, 2011
1442011
VAMP: visualization and analysis of array-CGH, transcriptome and other molecular profiles
PL Rosa, E Viara, P Hupé, G Pierron, S Liva, P Neuvial, I Brito, S Lair, ...
Bioinformatics 22 (17), 2066-2073, 2006
1202006
Spatial normalization of array-CGH data
P Neuvial, P Hupé, I Brito, S Liva, É Manié, C Brennetot, F Radvanyi, ...
BMC bioinformatics 7 (1), 264, 2006
1072006
Activated BRAF targets proximal colon tumors with mismatch repair deficiency and MLH1 inactivation
E Domingo, E Espín, M Armengol, C Oliveira, M Pinto, A Duval, ...
Genes, Chromosomes and Cancer 39 (2), 138-142, 2004
1072004
The mutator pathway is a feature of immunodeficiency-related lymphomas
A Duval, M Raphael, C Brennetot, H Poirel, O Buhard, A Aubry, A Martin, ...
Proceedings of the National Academy of Sciences 101 (14), 5002-5007, 2004
942004
Heterogeneity of neuroblastoma cell identity defined by transcriptional circuitries
V Boeva, C Louis-Brennetot, A Peltier, S Durand, C Pierre-Eugene, ...
Nature genetics 49 (9), 1408, 2017
842017
Mononucleotide repeats BAT‐26 and BAT‐25 accurately detect MSI‐H tumors and predict tumor content: Implications for population screening
C Brennetot, O Buhard, F Jourdan, JF Flejou, A Duval, R Hamelin
International journal of cancer 113 (3), 446-450, 2005
662005
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma
A Cazes, L Lopez-Delisle, K Tsarovina, C Pierre-Eugène, K De Preter, ...
Oncotarget 5 (9), 2688, 2014
542014
Breakpoint features of genomic rearrangements in neuroblastoma with unbalanced translocations and chromothripsis
V Boeva, S Jouannet, R Daveau, V Combaret, C Pierre-Eugene, A Cazes, ...
PloS one 8 (8), 2013
542013
The CDKN2A/CDKN2B/CDK4/CCND1 pathway is pivotal in well‐differentiated and dedifferentiated liposarcoma oncogenesis. An analysis of 104 tumors
C Louis‐Brennetot, JM Coindre, C Ferreira, G Pérot, P Terrier, A Aurias
Genes, Chromosomes and Cancer 50 (11), 896-907, 2011
462011
Characterization of rearrangements involving the ALK gene reveals a novel truncated form associated with tumor aggressiveness in neuroblastoma
A Cazes, C Louis-Brennetot, P Mazot, F Dingli, B Lombard, V Boeva, ...
Cancer research 73 (1), 195-204, 2013
442013
Frequent Ki-ras mutations in gastric tumors of the MSI phenotype
C Brennetot, A Duval, R Hamelin, M Pinto, C Oliveira, R Seruca, ...
Gastroenterology 125 (4), 1282-1283, 2003
252003
Dedifferentiated liposarcoma of the pleura mimicking a malignant solitary fibrous tumor and associated with dedifferentiated liposarcoma of the mediastinum: usefulness of …
M Benchetritt, V Hofman, N Vénissac, C Brennetot, A Italiano, A Aurias, ...
Cancer genetics and cytogenetics 179 (2), 150-155, 2007
222007
Ovarian dysgerminoma and Apert syndrome
C Rouzier, C Soler, P Hofman, C Brennetot, E Bieth, F Pedeutour
Pediatric blood & cancer 50 (3), 696-698, 2008
172008
Activated ALK signals through the ERK–ETV5–RET pathway to drive neuroblastoma oncogenesis
L Lopez-Delisle, C Pierre-Eugène, C Louis-Brennetot, D Surdez, ...
Oncogene 37 (11), 1417-1429, 2018
152018
Activated Alk triggers prolonged neurogenesis and Ret upregulation providing a therapeutic target in ALK-mutated neuroblastoma. Oncotarget. 2014; 5: 2688–702
A Cazes, L Lopez-Delisle, K Tsarovina, C Pierre-Eugène, K De Preter, ...
Epub 2014/05/09, 1883
81883
The system can't perform the operation now. Try again later.
Articles 1–20